Abstract:Lung cancer is the leading cause of cancer death due, in part, to lack of early diagnostic tools. Bronchoscopy represents a relatively noninvasive initial diagnostic test in smokers with suspect disease, but it has low sensitivity. We have reported a gene expression profile in cytologically normal large airway epithelium obtained via bronchoscopic brushings, which is a sensitive and specific biomarker for lung cancer. Here, we evaluate the independence of the biomarker from other clinical risk factors and determine the performance of a clinicogenomic model that combines clinical factors and gene expression. Training (n = 76) and test (n = 62) sets consisted of smokers undergoing bronchoscopy for suspicion of lung cancer at five medical centers. Logistic regression models describing the likelihood of having lung cancer using the biomarker, clinical factors, and these data combined were tested using the independent set of patients with nondiagnostic bronchoscopies. The model predictions were also compared with physicians' clinical assessment. The gene expression biomarker is associated with cancer status in the combined clinicogenomic model (P < 0.005). There is a significant difference in performance of the clinicogenomic relative to the clinical model (P < 0.05). In the test set, the clinicogenomic model increases sensitivity and negative predictive value to 100% and results in higher specificity (91%) and positive predictive value (81%) compared with other models. The clinicogenomic model has high accuracy where physician assessment is most uncertain. The airway gene expression biomarker provides information about the likelihood of lung cancer not captured by clinical factors, and the clinicogenomic model has the highest prediction accuracy. These findings suggest that use of the clinicogenomic model may expedite more invasive testing and definitive therapy for smokers with lung cancer and reduce invasive diagnostic procedures for individuals without lung cancer.

Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction Model

Recognition of Lung Adenocarcinoma-specific Gene Pair Based on Genetic Algorithm and Establishment of a Deep Learning Prediction Model.

LUADpp: an Effective Prediction Model on Prognosis of Lung Adenocarcinomas Based on Somatic Mutational Features

Multi-omics with Dynamic Network Biomarker Algorithm Prefigures Organ-Specific Metastasis of Lung Adenocarcinoma

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

[Prediction of Gene Mutation in Lung Cancer Based on Deep Learning and Histomorphology Analysis].

A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features

A Novel Deep Learning Method to Predict Lung Cancer Long-Term Survival With Biological Knowledge Incorporated Gene Expression Images and Clinical Data

Multiomics-Based Feature Extraction and Selection for the Prediction of Lung Cancer Survival

Enhancing Lung Cancer Classification and Prediction With Deep Learning and Multi-Omics Data

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data.

Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study

Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques

Deep-Learning Algorithm and Concomitant Biomarker Identification for NSCLC Prediction Using Multi-Omics Data Integration

Lung adenocarcinoma identification based on hybrid feature selections and attentional convolutional neural networks

A Deep Learning-Based Multi-Model Ensemble Method for Cancer Prediction.

Predicting non-small cell lung cancer-related genes by a new network-based machine learning method

Predicting Gene Comutation of EGFR and TP53 by Radiomics and Deep Learning in Patients With Lung Adenocarcinomas

Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS‐COV‐2 and lung adenocarcinoma crosstalk genes